Dealer’s Licence Fees and Timeline: SGD 1,110 per Year, 10 Working Days
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The Dealer’s Licence in Singapore costs SGD 1,110 for a new application and the same SGD 1,110 for each annual renewal, with an official review period of 10 working days and a validity of 12 months. A variation costs SGD 168. Under GN-02 R8, effective 1 April 2026, HSA provides automatic renewal for GIRO payment users and issues reminder emails 60, 45 and 30 calendar days before expiry. Changes to risk classification, QMS certification and premises information must be notified to HSA. Applications are filed through SHARE, which requires CorpPass for the Singapore entity.
- One fee, two moments. A new application and an annual renewal both cost SGD 1,110, so the fee recurs every 12 months.
- Cost scales with the licence count. An importer’s licence plus a wholesaler’s licence is SGD 2,220 per year, not SGD 1,110.
- Ten working days is review time only. Entity set-up, CorpPass, SHARE access and QMS audit reports sit outside that clock.
- Twelve months is a hard validity. Renewal is a fixed annual action, not a rolling obligation that can be deferred.
- Three change triggers. Risk classification, QMS certification and premises information must be notified and handled as a variation at SGD 168.
- Reminders are not a control. HSA emails help, but the renewal date belongs in the company’s own compliance calendar.
2. Legal basis
GN-02 R8, the Guidance on Licensing of Manufacturers, Importers and Wholesalers of MD, effective 1 April 2026, sets the licensing framework and the administrative parameters that accompany it. The fee, the review period, the validity and the renewal reminder schedule all sit in that guidance and on the HSA fees page. Filing is through SHARE, which is accessible with CorpPass. The substantive prohibition on unlicensed activity remains in Part VI of the Health Products Act 2007, so the fee schedule should be read as the administrative layer over a statutory requirement rather than as a stand-alone price list.
| Guidance | GN-02 R8, Guidance on Licensing of Manufacturers, Importers and Wholesalers of MD (effective 1 April 2026) |
| Fees | New application or annual renewal SGD 1,110; variation SGD 168 |
| Review period | 10 working days |
| Validity | 12 months |
| Renewal reminders | Emails at 60, 45 and 30 calendar days before expiry (GIRO users) |
| Notifiable changes | Risk classification, QMS certification, premises information |
| Filing system | SHARE, requiring CorpPass |
3. Expert insights
SGD 1,110 is a cost per licence per year, so a combined licence position multiplies. An importer’s licence plus a wholesaler’s licence comes to SGD 2,220 a year. When we build an annual compliance budget for a client, we calculate the number of licences multiplied by SGD 1,110 rather than entering a single company-level line. The difference matters in groups that operate several entities, because each entity holds its own licences and each licence is renewed on its own date. A budget built on a single line tends to be approved and then quietly exceeded.
Ten working days is the official review, not a promise that a certificate arrives in ten days. The prerequisites include a Singapore entity, CorpPass credentials, SHARE access, and QMS certification together with the audit report that GN-02 R8 makes compulsory. None of that preparation time is counted in the 10 working days. In scheduling we usually allow 4 to 8 weeks for the whole licensing chain, from entity readiness to certificate issuance, because the QMS documentation is normally the critical path and it depends on a certification body rather than on the applicant alone.
The licence is valid for 12 months, so renewal is a rigid annual action. Unlike product registration, which is maintained through an annual retention fee and has no expiry date, a dealer’s licence has a defined term. HSA offers GIRO auto-renewal and sends reminders at three intervals, which is helpful but not sufficient. Corporate email addresses change, staff leave and shared inboxes go unread, and a missed renewal interrupts the ability to import or wholesale lawfully. In the services we manage for clients, renewal is an internal calendar event with a named owner, and the HSA email is treated as confirmation rather than as the trigger.
Three categories of change must be notified to HSA. HSA lists the changes that require notification as the risk classification of the medical device, the QMS certification and the premises information. A change in any of the three is handled as a licence variation at SGD 168. Premises deserve particular attention: moving to a new warehouse without updating the licence raises the storage premises issue under section 14(2) of the Health Products Act 2007, which requires health products awaiting distribution to be stored at premises authorised under the licence. The variation fee is trivial compared with the compliance finding that follows an uninformed move.
Licensing and product registration are two independent annual actions. The two obligations are easy to merge mentally and should be kept apart operationally. Product registration is maintained by the retention fee of SGD 39 for Class B, SGD 67 for Class C or SGD 134 for Class D, and it does not expire while the fee is paid. The dealer’s licence is renewed every 12 months at SGD 1,110 per licence. Both must be performed, their dates usually differ, and the responsible teams may not even sit in the same department. A single annual compliance review that lists both, with separate owners and separate evidence, is the simplest way to keep them from colliding.
| Action | Frequency | Fee |
| Product registration retention fee | Annual | Class B SGD 39 / C SGD 67 / D SGD 134 |
| Dealer’s licence renewal | Annual (12 months) | SGD 1,110 per licence |
4. Practical recommendations
- Budget by licence count. Multiply the number of licences by SGD 1,110 and add the variation provision at SGD 168 per expected change.
- Allow 4 to 8 weeks for licensing. Include entity set-up, CorpPass, SHARE access and the QMS certificate and audit report in the plan.
- Make renewal an internal calendar event. Assign an owner and an escalation contact instead of relying on HSA reminder emails.
- File variations promptly. Risk classification, QMS and premises changes should be notified as they happen, not at renewal.
- Keep the two annual actions separate. Manage licence renewal and registration retention on distinct lines with distinct owners.
5. Verification checklist
- □ The number of licences required has been confirmed and the annual cost calculated
- □ 4 to 8 weeks has been reserved for licensing, including prerequisites
- □ Renewal dates are recorded in the internal compliance calendar
- □ Variation procedures for risk classification, QMS and premises are defined at SGD 168
- □ Licence renewal and registration retention are managed separately
- □ QMS certificate and audit report are available and current under GN-02 R8
Regulatory information verified as of 26 October 2026. Source tiers: secondary (GN-02 R8, HSA fees page, HSA dealer licensing page).
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Singapore. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with HSA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us